Market Overview

Pacific Biosciences of California, Inc. (NASDAQ: PACB)

20.18 +1.23 (6.49%)

Analyst Ratings

DateResearch FirmActionCurrentPT
11/04/20Morgan StanleyMaintainsEqual-Weight12.0
11/03/20Piper SandlerDowngradesNeutral
10/02/20JP MorganUpgradesOverweight15.0
10/01/20Piper SandlerMaintainsOverweight12.0
9/09/20Morgan StanleyInitiates Coverage OnEqual-Weight7.0
6/02/20Cantor FitzgeraldAssumesOverweight5.0
3/09/20Cantor FitzgeraldAssumesOverweight5.0
10/15/19Piper JaffrayUpgradesOverweight8.0
4/02/19Stephens & Co.DowngradesEqual-Weight8.0
1/04/19Cowen & Co.DowngradesMarket Perform

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter